Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

396

HTML

2864

Figures (1-2)

204

Tables (1-1)

194

Sum=3658

Publishing Process of This Article

Item

Count

Browse

1144

Download

972

Sum=2116

Aug 6, 2013 (publication date) through Nov 17, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastrointest Pharmacol Ther. Aug 6, 2013; 4(3): 69-79
Published online Aug 6, 2013. doi: 10.4292/wjgpt.v4.i3.69

Full Size Figure Download Figure

Figure 1 Flow chart showing process of study selection and data extraction.

Citation: Beales ILP, Hensley A, Loke Y. Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition. World J Gastrointest Pharmacol Ther 2013; 4(3): 69-79
URL: https://www.wjgnet.com/2150-5349/full/v4/i3/69.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v4.i3.69